Literature DB >> 12467967

Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome.

Motohiko Okano1.   

Abstract

Epstein-Barr virus (EBV) is an ubiquitous human herpesvirus. Its infection is generally subclinical. However, in certain circumstances, EBV causes infectious mononucleosis (IM) and lymphoproliferative disorders (LPD) in immunologically compromised individuals. Furthermore, EBV infection is etiologically linked to human malignancies such as Burkitt's lymphoma (BL), nasopharyngeal carcinoma (NPC) and miscellaneous malignant diseases because of the presence of viral genome in their tumor tissues. Since the late 1970s, a chronic undefined illness possibly associated with EBV infection, named such as severe chronic active EBV infection syndrome (SCAEBV), has been of interest due to its unique manifestations that often result in a poor prognosis. This review is an overview of SCAEBV with respect to its; history, diagnosis, pathogenesis, therapeutic approaches, and ideas on how to further recognize this enigmatic disease.

Entities:  

Mesh:

Year:  2002        PMID: 12467967     DOI: 10.1016/s1040-8428(02)00118-x

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  17 in total

1.  Lymphoma Mimicking Chronic Active Epstein-Barr Virus: A Case Report.

Authors:  Rohini Bahethi; Mingyang Gray; Christian Salib; Ilya Likhterov
Journal:  Head Neck Pathol       Date:  2020-04-29

2.  An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection.

Authors:  Chongfeng Xu; Junhong Ai; Qingxun Zhang; Ting Li; Xiaorong Wu; Zhengde Xie; Ziyuan Duan
Journal:  J Vis Exp       Date:  2018-03-30       Impact factor: 1.355

3.  Epstein-Barr Virus EA-IgA, VCA-IgA, and EBVNA-IgG Antibodies in a Population of Wuhan, China.

Authors:  Zhen-Gang Tang; Hui-Hui Li; Yun-Cheng Li; Mei-Xia Lv; Xin Xu; Jun-Chao Zeng; Wei-Jia Kong; Rui Yang
Journal:  Curr Med Sci       Date:  2020-03-13

4.  Expression of Epstein-Barr virus in children with sacrococcygeal pilonidal sinus determined by immunohistochemical methods.

Authors:  Esra Karakuş; Ayper Kaçar; Resul Karakuş; Ervin Mambet; Atilla Şenaylı
Journal:  Int Wound J       Date:  2014-04-24       Impact factor: 3.315

5.  Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.

Authors:  Jan Rohr; Karin Beutel; Andrea Maul-Pavicic; Thomas Vraetz; Jens Thiel; Klaus Warnatz; Ilka Bondzio; Ute Gross-Wieltsch; Michael Schündeln; Barbara Schütz; Wilhelm Woessmann; Andreas H Groll; Brigitte Strahm; Julia Pagel; Carsten Speckmann; Gritta Janka; Gillian Griffiths; Klaus Schwarz; Udo zur Stadt; Stephan Ehl
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

6.  Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection.

Authors:  S Toyabe; W Harada; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  EBV Chronic Infections.

Authors:  Pizzigallo Eligio; Racciatti Delia; Gorgoretti Valeria
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-10       Impact factor: 2.576

8.  Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.

Authors:  Ken-ichi Imadome; Misako Yajima; Ayako Arai; Atsuko Nakazawa; Fuyuko Kawano; Sayumi Ichikawa; Norio Shimizu; Naoki Yamamoto; Tomohiro Morio; Shouichi Ohga; Hiroyuki Nakamura; Mamoru Ito; Osamu Miura; Jun Komano; Shigeyoshi Fujiwara
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

9.  Severe chronic active EBV infection in an adult patient: case report.

Authors:  Sang-Yoon Ha; Chul-Won Chung; Young H Ko
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

10.  A case of severe chronic active Epstein-Barr virus infection with T-cell lymphoproliferative disorder.

Authors:  Hyun Seok Cho; In Soon Kim; Hwan Cheol Park; Myung Ju Ahn; Young Yiul Lee; Chan Kum Park
Journal:  Korean J Intern Med       Date:  2004-06       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.